JVMCX
Price
$27.01
Change
+$0.05 (+0.19%)
Updated
Aug 8 closing price
Net Assets
23.23B
TSVIX
Price
$28.05
Change
+$0.06 (+0.21%)
Updated
Aug 8 closing price
Net Assets
629.42M
Interact to see
Advertisement

JVMCX vs TSVIX

Header iconJVMCX vs TSVIX Comparison
Open Charts JVMCX vs TSVIXBanner chart's image
JHancock Disciplined Value Mid Cap C
Price$27.01
Change+$0.05 (+0.19%)
VolumeN/A
Net Assets23.23B
Transamerica Small/Mid Cap Value I
Price$28.05
Change+$0.06 (+0.21%)
VolumeN/A
Net Assets629.42M
JVMCX vs TSVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVMCX vs. TSVIX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and TSVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 23.2B vs. TSVIX (629M). TSVIX pays higher dividends than JVMCX: TSVIX (1.01) vs JVMCX (0.00). JVMCX was incepted earlier than TSVIX: JVMCX (14 years) vs TSVIX (16 years). JVMCX (1.88) is less costly to investors than TSVIX (0.89). JVMCX is a more actively managed with annual turnover of: 49.00 vs. TSVIX (46.00). JVMCX has a lower initial minimum investment than TSVIX: JVMCX (1000) vs TSVIX (1000000). JVMCX annual gain was more profitable for investors over the last year : 0.26 vs. TSVIX (-5.35). JVMCX return over 5 years is better than : 43.92 vs. TSVIX (24.88).
JVMCXTSVIXJVMCX / TSVIX
Total Expense Ratio1.870.89210%
Annual Report Gross Expense Ratio1.880.89211%
Fund Existence14 years16 years-
Gain YTD6.7592.000338%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets23.2B629M3,688%
Annual Yield % from dividends0.001.01-
Returns for 1 year0.26-5.35-5%
Returns for 3 years12.23-4.60-266%
Returns for 5 years43.9224.88177%
Returns for 10 years32.106.16521%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EHC117.581.07
+0.92%
Encompass Health Corp
NPCE8.980.06
+0.67%
Neuropace
QETAU10.84N/A
N/A
Quetta Acquisition Corp
BGI0.63-0.01
-1.03%
Birks Group
GOGL8.52-0.30
-3.40%
Golden Ocean Group Limited